Response to “Preserved” glucagon secretion in fulminant type 1 diabetes

We compared the glucagon responses to arginine stimulation in five patients with fulminant type 1 diabetes and five age‐ and diabetes duration‐matched acute‐onset type 1 diabetes, and the curves of the glucagon responses were similar. In our study, we measured the glucagon levels by not only radioim...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Nobuyuki, Chujo, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319494/
https://www.ncbi.nlm.nih.gov/pubmed/30520259
http://dx.doi.org/10.1111/jdi.12972
_version_ 1783385070930755584
author Takahashi, Nobuyuki
Chujo, Daisuke
author_facet Takahashi, Nobuyuki
Chujo, Daisuke
author_sort Takahashi, Nobuyuki
collection PubMed
description We compared the glucagon responses to arginine stimulation in five patients with fulminant type 1 diabetes and five age‐ and diabetes duration‐matched acute‐onset type 1 diabetes, and the curves of the glucagon responses were similar. In our study, we measured the glucagon levels by not only radioimmunoassay, but also novel enzyme‐linked immunosorbent assay.[Image: see text]
format Online
Article
Text
id pubmed-6319494
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63194942019-01-08 Response to “Preserved” glucagon secretion in fulminant type 1 diabetes Takahashi, Nobuyuki Chujo, Daisuke J Diabetes Investig Letters to the Editor We compared the glucagon responses to arginine stimulation in five patients with fulminant type 1 diabetes and five age‐ and diabetes duration‐matched acute‐onset type 1 diabetes, and the curves of the glucagon responses were similar. In our study, we measured the glucagon levels by not only radioimmunoassay, but also novel enzyme‐linked immunosorbent assay.[Image: see text] John Wiley and Sons Inc. 2018-12-06 2019-01 /pmc/articles/PMC6319494/ /pubmed/30520259 http://dx.doi.org/10.1111/jdi.12972 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters to the Editor
Takahashi, Nobuyuki
Chujo, Daisuke
Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
title Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
title_full Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
title_fullStr Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
title_full_unstemmed Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
title_short Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
title_sort response to “preserved” glucagon secretion in fulminant type 1 diabetes
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319494/
https://www.ncbi.nlm.nih.gov/pubmed/30520259
http://dx.doi.org/10.1111/jdi.12972
work_keys_str_mv AT takahashinobuyuki responsetopreservedglucagonsecretioninfulminanttype1diabetes
AT chujodaisuke responsetopreservedglucagonsecretioninfulminanttype1diabetes

Ejemplares similares